Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5362_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Carbon Based Nanomaterials for Drug Delivery
- •Preface
- •Acknowledgements
- •Contents
- •Editor and Contributors
- •Abbreviations
- •1.2 Market Statistics
- •Carbon-Based Nanomaterials: An Overview
- •1. Introduction
- •1.1 Evolution of Carbon-Based Nanomaterials
- •2. Carbon-Based Nanostructures
- •2.1 Fullerene
- •2.2 Carbon Nanotubes (CNTs)
- •2.4 Graphene
- •2.5 Nanodiamonds (NDs)
- •2.6 Nano-Onions (CNOs)
- •2.7 Nanohorns (CNHs)
- •2.8 Carbon Dots (CDs)
- •2.9 Nanoporous Activated Carbon
- •3. Synthesis Techniques
- •4. Properties of Carbon-Based Nanomaterials
- •4.1 Physicochemical Properties
- •4.2 Thermal Properties
- •4.3 Mechanical Properties
- •4.4 Optoelectronic Properties
- •4.5 Antimicrobial Properties
- •4.6 Biological Properties
- •5. Applications of Carbon-Based Nanomaterials
- •5.1 Environmental Remediation
- •5.2 Agriculture
- •5.3 Biofuel
- •5.4 Energy Storage
- •5.5 Biomedical Applications
- •6. Challenges and Future Perspectives
- •7. Concluding Remarks
- •References
- •Carbon-Based Nanostructured Materials: Designing, Properties and Applications
- •1. Introduction
- •2.1 Zero-Dimensional Carbon-Based Nanostructures (0D)
- •2.2 One-Dimensional Carbon-Based Nanostructures
- •2.3 Two-Dimensional (2D) Carbon-Based Nanostructures
- •2.4 Three-Dimensional (3D) Carbon-Based Nanostructures
- •3.1 Chemical Vapor Deposition
- •3.2 Hydrothermal and Solvothermal Techniques
- •3.3 Microwave-Assisted Technique
- •3.4 Chemical Oxidation Synthesis
- •4. Properties of Carbon-Based Nanostructured Materials
- •4.1 Thermal Properties
- •4.2 Mechanical Properties
- •4.3 Optoelectronic Properties
- •4.4 Antimicrobial Properties
- •4.5 Biological Properties
- •5. Applications of Carbon-Based Nanostructured Materials
- •5.2 Antibacterial and Antiviral Applications
- •5.3 Theragnostic
- •5.4 Wound Healing
- •5.5 Tissue Engineering
- •5.6 Drug Delivery
- •5.7 Biosensing
- •6. Challenges and Future Perspectives
- •7. Concluding Remarks
- •References
- •Drug Delivery System and Technologies
- •1. Introduction
- •2. Drug Delivery System
- •2.1 Conventional Drug Delivery System
- •2.2 Advanced Drug Delivery System
- •2.3 Controlled and Sustainable Drug Delivery System
- •3. Drug Delivery Technologies
- •3.1 Active and Passive Drug Delivery
- •3.2 Smart Drug Delivery
- •3.3 Intravenous and Extravaneous Drug Delivery
- •3.4 Various Types of Delivery Technologies
- •4. Challenges and Future Perspectives
- •5. Conclusion
- •References
- •Carbon-Based Nanomaterials for Drug Delivery: Past, Present, Future Directions
- •1. Introduction
- •3. Current Status in Drug Delivery by CNMs
- •3.1 Graphene-Based Nanomaterials in Drug Delivery
- •3.4 Nanodiamond Based Drug Delivery Systems
- •3.5 Nano-Onions in Drug Delivery
- •3.6 Nanohorns in Drug Delivery
- •3.7 Fullerene in Drug Delivery
- •4. Challenges and Future Perspective
- •5. Conclusions
- •References
- •Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery
- •1. Introduction
- •2. Different Carbon Nanomaterials in Drug Delivery
- •2.1 Carbon Nanotubes (CNTs)
- •2.3 Graphene
- •2.4 Carbon Quantum Dots
- •2.5 Fullerene
- •2.6 Carbon Nanohorns
- •2.7 Carbon Nano-Onions
- •2.8 Nano-Diamond
- •3. Supramolecular Chemistry in Drug Delivery
- •3.1 Principles of Supramolecular Chemistry
- •3.3 Applications of Supramolecular Biomaterials
- •4. Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery
- •5.1 Cyclodextrins
- •5.2 Calixarenes
- •5.3 Cucurbituril
- •5.4 Pillarenes
- •5.5 Crown Ether
- •6. Toxicity Concerns of Carbon Nanomaterials
- •7. Improving the Effectiveness of Nanoparticle Systems
- •8. Future of Nanomedicine
- •9.1 Challenges
- •9.2 Future Perspectives and Opportunities
- •9.3 Conclusions
- •References
- •Carbon Nanomaterial-Based Polymeric Nanocomposites for Drug Delivery
- •1. Introduction
- •2.1 Carbon Quantum Dot-Based Polymer Nanocomposite
- •2.2 Carbon Nanotube-Based Polymer Nanocomposite
- •2.3 Graphene Quantum Dot-Based Polymer Nanocomposite
- •2.5 Fullerene-Based Polymer Nanocomposite
- •2.6 Nanodiamond-Based Polymer Nanocomposite
- •3. Drug Delivery Systems Using Carbon Nanomaterial
- •3.1 Anticancer Drug Delivery
- •3.3 Infectious Disease Drug Delivery
- •3.4 Topical Drug Delivery
- •3.5 Brain Drug Delivery
- •3.6 Oral Drug Delivery
- •4. Challenge and Future Perspectives
- •5. Conclusion
- •References
- •Carbon Nanomaterial-Incorporated Polysaccharide-Based Nanocomposite for Drug Delivery
- •1. Introduction
- •1.1 Drug Delivery
- •1.2 Carbon Nanomaterials
- •1.3 Polysaccharide-Based Nanocomposite
- •2.1 CN-Incorporated Alginate-Based Nanocomposite
- •2.2 CN-Incorporated Cellulose-Based Nanocomposite
- •2.3 CN-Incorporated Chitosan-Based Nanocomposite
- •2.4 CN-Incorporated Dextran-Based Nanocomposite
- •2.5 CN-Incorporated Hyaluronic Acid-Based Nanocomposite
- •2.6 CN-Incorporated Starch-Based Nanocomposite
- •2.7 CN-Incorporated Pectin-Based Nanocomposite
- •2.8 CN-Incorporated Guar Gum-Based Nanocomposite
- •2.9 CN-Incorporated Agarose-Based Nanocomposite
- •2.10 CN-Incorporated Carrageenan-Based Nanocomposite
- •2.11 CN-Incorporated Glucomannan-Based Nanocomposite
- •3. Challenges and Future Prospective
- •4. Concluding Remarks
- •References
- •Graphene-Based Nanomaterials for Drug Delivery
- •1. Introduction
- •1.1 Challenges in Conventional Drug Delivery Systems
- •1.2 Overview of Nanomaterials for Drug Delivery
- •1.3 Role of Graphene-Based Nanomaterials in Drug Delivery
- •2. Synthesis of Graphene
- •2.1 Chemical Reduction Method
- •2.2 Thermal Reduction
- •2.3 Electrochemical Reduction
- •2.4 Chemical Vapor Deposition Method
- •2.5 Mechanical Exfoliation
- •2.6 Epitaxial Growth Method
- •2.7 Growth in Solvothermal and Hydrothermal Systems
- •2.8 Electrochemical Deposition
- •3. Types of Graphene-Based Materials
- •3.1 Graphene Quantum Dots, (GQDs)
- •3.2 Graphene Oxide (GO)
- •3.3 Graphene Nanoribbons (GNRs)
- •3.4 Oxidized Graphene Nanoribbons
- •4. Graphene Functionalized Materials for Drug Delivery
- •4.1 In Bone Tissue Regeneration
- •4.2 In Neural Regeneration
- •4.3 In Photodynamic and Photothermal Therapy
- •4.4 In Enhancing Cellular and Humoral Immunity
- •4.6 Miscellaneous
- •5. Challenges and Future Perspective
- •6. Conclusion
- •References
- •Carbon Quantum Dots Based Materials for Drug Delivery
- •1. Introduction
- •2. Synthesis Process of Carbon Quantum Dots
- •2.1 Top-Down Approaches
- •2.2 Bottom-Up Approaches
- •2.3 Microwave-Assisted Method
- •2.4 Electrochemical Method
- •2.5 Laser Ablation Method
- •2.6 Pyrolysis Method
- •2.7 Template-Assisted Method
- •4. Challenges and Future Perspective
- •5. Concluding Remarks
- •References
- •Carbon-based Nanocarriers for Sustained Drug Release in Dentistry
- •1. Introduction
- •2.1 Oral Mucosa Structure
- •2.2 Sites for Drug Delivery
- •2.3 Permeability
- •3. Local Drug Delivery for Dental Diseases
- •3.1 Odontogenic Infection
- •3.2 Non-odontogenic Infection
- •4. Bio-adhesive Nanoparticles: Novel Treatment Modality
- •4.1 Bio-adhesive Nanoparticles
- •4.2 Mechanism of Bioadhesion
- •5.1 Carbon Nanotubes
- •5.2 Graphene
- •5.3 Nanodiamonds
- •5.4 Fullerenes
- •5.5 Porous Carbon
- •5.6 Carbon Dots
- •6. Drug Delivery Systems Based on CBNs
- •6.2 Immediate Drug Delivery System (IDDS)
- •6.3 Sustained-release Drug Delivery Systems
- •6.4 Controlled Drug Delivery System (CDDs)
- •8. Conclusion
- •References
- •Fullerene Based Materials for Drug Delivery
- •1. Introduction
- •2. Types of Fullerene Derivatives
- •2.1 Exohedral Fullerene Derivatives
- •2.2 Endohedral Fullerene Derivatives
- •2.3 Surface Derivatized Fullerenes
- •3. Interaction of Fullerene Derivatives for Drug Delivery
- •4. Fullerene Based Materials for Drug Delivery
- •4.1 Nucleic Acid Delivery
- •4.2 Peptide Delivery
- •4.3 Topical Drug Delivery
- •4.4 Infectious Diseases Drug Delivery
- •4.5 Anticancer Drug Delivery
- •4.7 Brain Drug Delivery
- •4.8 Ocular Drug Delivery
- •5. Challenges and Future Perspectives
- •6. Concluding Remarks
- •6.1 Abbreviations
- •References
- •Graphene Quantum Dots-based Nanomaterials for Drug Delivery
- •1. Introduction
- •2. Synthesis of GQDs
- •3. GQD’s Properties for Drug Delivery
- •3.1 Optical Properties
- •3.2 Physicochemical Properties
- •3.3 Mechanical Properties
- •3.4 Biocompatibility and Cytotoxicity
- •4. Characterization of GQDs-Based Nanomaterials
- •4.1 Characterization of Multifunctional GQDs-Based Nanomaterials
- •5.1 Strategies for Developing Medication Delivery Systems Based on GQD
- •5.2 PH-responsive Drug Delivery Systems (GQD-DDSs)
- •5.3 Targeted Drug Delivery Using Ligand-Based GQDs as a Mediator
- •5.4 Improvement of Medicines’ Pharmacological Properties Using GQDs
- •5.5 Enhancing Cytotoxicity with GQD-DDS
- •7. Applications of Chiral GQDs
- •10. Challenges and Future Perspectives
- •11. Conclusions
- •References
- •Carbon Nano-onions for Drug Delivery
- •1. Introduction
- •2. Carbon Nano-Onion: A Multi-Layered Nanocarrier
- •3. Synthesis of Carbon Nano-Onions
- •3.1 Annealing Method
- •3.2 Carbon Ion Implantation Method
- •3.3 Arc Discharge Method
- •3.4 Carbon Vapour Deposition Method
- •3.5 Pyrolysis Method
- •6. Carbon Nano-Onions in Drug Delivery
- •6.1 Delivery of Therapeutic Agents
- •6.2 Delivery of Targeting Agents
- •6.3 Delivery of Imaging Agents
- •7. Challenges and Future Perspectives
- •8. Concluding Remarks
- •References
- •Chitosan/Carbon Nanocomposites in Drug Delivery and Cardiovascular Diseases
- •1. Introduction
- •1.1 Drug Delivery
- •1.2 Cardiovascular Diseases
- •1.3 Chitosan and Its Properties
- •1.4 Chitosan/Carbon Nanocomposites
- •2. Chitosan/Carbon Nanocomposites in Drug Delivery
- •3. Chitosan/Carbon Nanocomposites in CVDs
- •3.1 Chitosan-Based Scaffolds
- •3.2 Chitosan in Cardiac Tissue Engineering
- •3.3 Chitosan-Based Cell Therapy
- •3.4 Chitosan-Based Gene Delivery
- •3.5 Chitosan-Protein Interaction
- •4. Challenges and Future Perspective
- •5. Concluding Remarks
- •References
- •Graphene Reinforced Chitosan Nanocomposites for Drug Delivery
- •1. Introduction
- •2. Chitosan: Structure and Properties
- •3. Graphene: Structure, Types and Properties
- •4.1 Electrospinning Method
- •4.2 Sol–gel Method
- •4.3 Solution Mixing Method
- •4.4 In-situ Polymerization Method
- •5.2 Chitosan/Graphene Aerogels
- •5.3 Chitosan/Graphene Hydrogels
- •5.4 Chitosan/Graphene Thin Films
- •6.1 Oral Drug Delivery
- •6.2 Mucosal Drug Delivery
- •6.3 Transdermal Drug Delivery
- •6.4 Parenteral Drug Delivery
- •7. Challenges and Future Perspectives
- •8. Concluding Remarks
- •References
- •1. Introduction
- •2. Functionalization of CNFs
- •2.1 The Need for Functionalization

Carbon Quantum Dots Based Materials for Drug Delivery 285
Tabl e 2 (continued)
CQDs based drug delivery system Materials of drug carrier system and its
Polypyrrole/mesoporous SiO2/
CQDs (PPy/mSiO
CQDs-concanavalinA @Fe3O
/CQDs)
2
4
drug release properties
This study investigated a photo-sensitive
nanocarrier of PPy/mSiO
the delivery of MTX as an active agent.
Their BET analysis demonstrated a
scale of 400 nm with a mean pore
diameter of 3 nm and a specific surface
area of 375.27 m
they employed NIR irradiation as the
external stimulus, PPy turned the light
to thermal energy, making H-bonds
broken among CQDs and mSiO
confirming the photo-sensitive drug
delivery application
This work suggests a pH-sensitive drug
delivery system of
CQDs-ConA@Fe
delivery system to carry DOX for
treating cervical cancer. In this regard,
the HeLa cell lines have been
employed. Moreover, in vitro cell
imaging has been implemented in a
magnetic field to confirm the DOX’s
existence in the Fe
Besides, their results revealed a specific
cancer cell as the main concanavalin A
target, bringing fewer side effects and
more therapy efficacy
2·g−1
/CQDs for
2
. Moreover, when
as a targeted
3O4
structure.
3O4
2
References
[]
,
[100]
cell types or tissues, increasing the accuracy and effectiveness of drug delivery.
Moreover, diverse fabrication techniques have been employed to engineer CQDs
with tailored properties, making them versatile nanocarriers with multifunctional
capabilities [106].
This opens up exciting avenues for theragnostic applications, where CQDs can
be used not only as carriers for drug delivery but also as imaging agents to monitor
treatment progress and response. The ability to integrate both therapeutic and diagnostic functions within a single system can revolutionize personalized medicine and
improve patient outcomes [107]. In summary, CQDs represent a promising class of
nanocarriers for drug delivery due to their ultrafine size, photoluminescent properties, and versatile surface functionalization options. While challenges in achieving
uniform size distribution and addressing cytotoxicity,ongoing research and optimization efforts are likely to propel CQDs into the forefront of theragnostic applications,
paving the way for highly efficient and targeted drug delivery systems in the field of
medicine.

286 M. Pourmadadi et al.
5 Concluding Remarks
In the current landscape of medical research, the development of smart and targeted
drug delivery applications has become increasingly important for the efficient treatment of various diseases. These applications involve the use of stimuli-sensitive
delivery platforms, which respond to specific triggers such as changes in pH, temperature, or exposure to light. By utilizing these platforms, scientists have been able to
minimize the occurrence of undesirable side effects while maximizing the therapeutic
efficacy of drugs. Despite the significant advancements in drug delivery sciences,
there still remain challenges in delivering drugs to specific areas of the body, particularly for the treatment of neurological diseases and cancers that are protected by
barriers such as the BBB and blood-tumor barrier BTB. These barriers pose significant challenges as they restrict the entry of drugs into the targeted regions, thereby
reducing the effectiveness of treatment.
Efforts are being made to overcome these challenges through the use of innovative
strategies. For instance, researchers are exploring the use of nanotechnology-based
drug delivery systems that can bypass these barriers and deliver of drugs directly to
the desired locations. Additionally,the developmentof targeted drug delivery systems
that can selectively bind to receptors expressed on the surface of diseased cells is
being investigated. Such systems would allow for enhanced drug accumulation at
the targeted sites, thereby improving treatment outcomes.
Although significant progress has been made in the field of drug delivery sciences,
the delivery of drugs to specific regions of the body, particularly to treat diseases
protected by barriers, remains a major challenge. Also, ongoing research and the
exploration of innovative strategies hold promise for the development of effective drug delivery systems that can overcome these barriers and improve treatment
outcomes for various diseases. To address this challenge, researchers have turned to
CQDs as a promising solution. CQDs possess an ultrafine size range of below 10 nm
and offer great functionalization capabilities through diverse synthesis processes.
This unique combination of properties allows them to serve as highly efficient drug
carriers with the potential for targeted delivery. By developing various CQD-based
materials, scientists have harnessed the active surface area of CQDs to protect drugs
and deliver them in a stimuli-sensitive manner to desired locations.
In the context of drug release, the chapter delved into the investigation of diverse
CQD-based delivery systems and their capabilities in theragnostic applications.
These delivery systems hold the promise of precisely releasing drugs at specific
locations within the body, leading to improved treatment outcomes and reduced side
effects. The concept of theragnostic applications refers to the integration of therapeutic and diagnostic functions within a single system. CQDs, with their inherent
fluorescence and imaging capabilities, can not only deliver drugs but also enable
real-time monitoring of drug distribution and treatment response. This level of precision and adaptability has the potential to revolutionize medical treatments, especially in personalized medicine. In conclusion, the represented chapter focuses on
exploring the drug release capabilities of various CQD-based delivery systems and

Carbon Quantum Dots Based Materials for Drug Delivery 287
highlights their promising potential in theragnostic applications. By harnessing the
unique properties of CQDs, scientists aim to overcome the challenges of delivering
drugs to specific locations within the body, offering new avenues for more effective and targeted treatments for neurological diseases, cancers, and other medical
conditions.
Conflict of Interest The authors declare that there is no conflict of interest in publishing this
article.
References
1. Yeganeh FE, Yeganeh AE, Far BF, Mansouri A, Sibuh BZ, Krishnan S, Pandit S, Alsanie
WF, Thakur VK, Gupta PK (2022) Synthesis and Characterization of Tetracycline Loaded
Methionine-Coated NiFe2O4 Nanoparticles for Anticancer and Antibacterial Applications.
Nanomater 12(13):2286
2. Tian L, Li Z, Wang P, Zhai X, Wang X, Li T (2021) Carbon quantum dots for advanced
electrocatalysis. J Energy Chem 55:279–294
3. Behboudi H, Mehdipour G, Safari N, Pourmadadi M, Saei A, Omidi M, Tayebi L, Rahmandoust M (2019) Carbon quantum dots in nanobiotechnology. In: Nanomaterials for advanced
biological applications, Springer, pp 145–79
4. Wang L, WangY, Xu T,Liao H, YaoC, Liu Y, Li Z, Chen Z, Pan D, Sun L, Wu M (2014) Gramscale synthesis of single-crystalline graphene quantum dots with superior optical properties.
Nat Commun 5(1):5357
5. Tao W, Kong N, Ji X, Zhang Y, Sharma A, Ouyang J, Qi B, Wang J, Xie N, Kang C, Zhang H,
Farokhzad OC, Kim JS (2019) Emerging two-dimensional monoelemental materials (Xenes)
for biomedical applications. Chem Soc Rev 201948(11):2891–2912
6. Singh AP, Biswas A, Shukla A, Maiti P (2019) Targeted therapy in chronic diseases using
nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther 4(1):33
7. Farasati Far B, Omrani M, Naimi Jamal MR, Javanshir S (2023) Multi-responsive chitosanbased hydrogels for controlled release of vincristine. Commun. Chem. 6(1):28
8. Nair A, Haponiuk JT, Thomas S, Gopi S (2020) Natural carbon-based quantum dots and their
applications in drug delivery: A review. Biomed Pharmacother 132:110834
9. Molaei MJ (2019) Carbon quantum dots and their biomedical and therapeutic applications: a
review. RSC Adv 9(12):6460–6481
10. J.K. Patra, G. Das, L.F. Fraceto, E. VvR. Campos, M. dP. Rodriguez-Torres, L.S. AcostaTorres, L.A. Diaz-Torres, L.A. Diaz-Torres, Renato Grillo, M. K. Swamy, S. Sharma, S.
Habtemariam, H.S. Shin. Nano based drug delivery systems: recent developments and future
prospects. J. Nanobiotech. 16(1), 1–33 (2018)
11. Kaur A, Pandey K, Kaur R, Vashishat N, Kaur M (2022) Nanocomposites of carbon quantum
dots and graphene quantum dots: environmental applications as sensors. Chemosensors
10(9):367
12. Farzin MA, Abdoos H (2021) A critical review on quantum dots: From synthesis toward
applications in electrochemical biosensors for determination of disease-related biomolecules.
Talanta 224:121828
13. Zhang L, Yang X, Yin Z, Sun L (2022) A review on carbon quantum dots: Synthesis,
photoluminescence mechanisms and applications. Lumin 37(10):1612–1638
14. de Boëver R, TownJR, Li X, Claverie JP (2022) Carbon dots for carbon dummies: the quantum
and the molecular questions among some others. Chem Eur J 28(47):202200748

288 M. Pourmadadi et al.
15. Rasal AS, Yadav S, Yadav A, Kashale AA, Manjunatha ST,Altaee A, Chang JY (2021) Carbon
quantum dots for energy applications: a review. ACS Appl. Nano Mater. 4(7):6515–6541
16. Yan Y, Nashath FZ, Chen S, Manickam S, Lim SS, Zhao H, Lester E, Wu T, Peng CH
(2020) Synthesis of graphene: Potential carbon precursors and approaches. Nanotechnol Rev
9(1):1284–1314
17. Dong WX, Qu YF, Liu X, Chen LF (2023) Biomass-derived two-dimensional carbon
materials: Synthetic strategies and electrochemical energy storage applications. FlatChem.
37:100467
18. Dubey P,Nimbalkar T, Sahu V, Bano S (2023) A review on synthesis and application of carbon
quantum dots. Eur. Chem. Bull. 12:1509–1518
19. Hagiwara K, Horikoshi S, Serpone N (2021) Photoluminescent carbon quantum dots: synthetic
approaches and photophysical properties. Chem Eur J 27(37):9466–9481
20. Ganguly S, Das P, Banerjee S, Das NC (2019) Advancement in science and technology of
carbon dot-polymer hybrid composites: a review. Funct. Compos. Struct. 1(2):022001
21. Kumar A, Dutta S, Kim S, Kwon T, Patil SS, Kumari N, Jeevanandham S, Lee S (2022)
Solid-state reaction synthesis of nanoscale materials: Strategies and applications. Chem Rev
122(15):12748–12863
22. V. Baumann, M. A. Habeeb Muhammed, A.J. Blanch, P. Dey, J. Rodríguez-Fernández,
Biomolecules in metal and semiconductor nanoparticle growth. Isr. J. Chem. 56(4), 195–213
(2016)
23. Ku KH, Shin JM, Yun H, Yi GR, Jang SG, Kim BJ (2018) Multidimensional Design
of Anisotropic Polymer Particles from Solvent-Evaporative Emulsion. Adv Funct Mater
28(42):1802961
24. Liu J, Li R, Yang B (2020) Carbon dots: A new type of carbon-based nanomaterial with wide
applications. ACS Cent Sci 6(12):2179–2195
25. Wang R, Lu KQ, Tang ZR, Xu YJ (2017) Recent progress in carbon quantum dots: synthesis,
properties and applications in photocatalysis. J. Mater. Chem. A 5(8):3717–3734
26. Cui L, Ren X, Sun M, Liu H, Xia L (2021) Carbon Dots: Synthesis. Properties and
Applications. Nanomater. 11(12):3419
27. Cao X, Ding C, Zhang C, Gu W, Yan Y, Shi X, Xian Y (2018) Transition metal dichalcogenide
quantum dots: synthesis, photoluminescence and biological applications. J Mater Chem B
6(48):8011–8036
28. K.P. Mubiayi, D.M.G. Neto, A. Morais, H.P. Nogueira, T.E. de Almeida Santos, T. Mazon,
N. Moloto, M.J. Moloto, J.N. Freitas. Microwave assisted synthesis of CuInGaSe2 quantum
dots and spray deposition of their composites with graphene oxide derivatives. Mater. Chem.
Phys. 242,122449 (2020)
29. Chauhan DS, Quraishi M, Verma C (2022) Carbon nanodots: recent advances in synthesis
and applications. Carbon Lett. 32(7):1603–1629
30. Raikwar V (2022) Synthesis and study of carbon quantum dots (CQDs) for enhancement
of luminescence intensity of CQD@ LaPO4: Eu3+ nanocomposite. Mater Chem Phys
275:125277
31. Rawat P, Nain P, Sharma S, Sharma PK, Malik V, Majumder S, Verma VP, Rout V, Rhyee JS
(2022) An overview of synthetic methods and applications of photoluminescence properties
of carbon quantum dots. Lumin 38(7):845–866
32. Xiong R, Zhang X, Krecker M, Kang S, Smith MJ, Tsukruk VV (2020) Large and emissive crystals from carbon quantum dots onto interfacial organized templates. Angew Chem
132(45):20342–20348
33. Ahirwar RC, Mehra S, Reddy SM, Alshamsi HA, Kadhem AA, Karmankar SB, Sharma
A (2023) Progression of Quantum Dots Confined Polymeric Systems for Sensorics. Polym
15(2):405
34. M. Pourmadadi, A. Shamsabadipour, A. Bhatti, M. Forouzanfar, M. Rajabnejad, R.
Behzadmehr, A. Rahdar, D.I. Medina, A.M. Díez-Pascual, Therapeutic performance of
temozolomide-loaded nanomaterials: A state-of-the-art. J. Drug Deliv. Sci. Technol. 104568
(2023)

Carbon Quantum Dots Based Materials for Drug Delivery 289
35. Feng T, Ai X, Ong H, Zhao Y (2016) Dual-responsive carbon dots for tumor extracellular
microenvironmenttriggered targeting and enhanced anticancer drug delivery.ACSAppl Mater
Interfaces 8(29):18732–18740
36. Gong X, Gong Q, Gao Y, Shuang S, Choi MM, Dong C (2016) Phosphorus and nitrogen dualdoped hollow carbon dot as a nanocarrier for doxorubicin delivery and biological imaging.
ACS Appl Mater Interfaces 8(18):11288–11297
37. Shu Y, Lu J, Mao QX, Song RS, Wang XY, Chen XW, Wang JH (2017) Ionic liquid mediated
organophilic carbon dots for drug delivery and bioimaging. C. 114: 324–33
38. Yang J, Gao G, Zhang X, Ma YH, Jia HR, Jiang YW, Wa ng Z, Wu FG (2017) Ultrasmall and
photostable nanotheranostic agents based on carbon quantum dots passivated with polyaminecontaining organosilane molecules. Nanoscale 9(40):15441–15452
39. Sung SY, Su YL, Su W, Su PF, Chiang CS, Chen WT, Hu SH (2018) Graphene quantum dotsmediated theranostic penetrative delivery of drug and photolytics in deep tumors by targeted
biomimetic nanosponges. Nano Lett 19(1):69–81
40. Li J, Yang S, Deng Y, Chai P, Yang Y, He X, Xie X, Kang Z, Ding G, Zhou H, Fan X
(2018) Emancipating target-functionalized carbon dots from autophagy vesicles for a novel
visualized tumor therapy. Adv Funct Mater 28(30):1800881
41. Zhang M, Wang W, Zhou N, Yuan P, Su Y, Shao M, Chi C, Pan F (2017) Near-infrared light
triggered photo-therapy, in combination with chemotherapy using magnetofluorescent carbon
quantum dots for effective cancer treating. C. 118, 752–64
42. Adam GO, Sharker SM, Ryu JH (2022) Emerging biomedical applications of carbon dot and
polymer composite materials. Appl Sci 12(20):10565
43. Sharker SM, Do M (2021) Nanoscale carbon-polymer dots for theranostics and biomedical
exploration. J. Nanotheranostics 2(3):118–130
44. Li S, Peng Z, Dallman J, Baker J, Othman AM, Blackwelder PL, Leblanc RM (2016) Crossing
the blood–brain–barrier with transferrin conjugated carbon dots: A zebrafish model study.
Colloids Surf B 145:251–256
45. Emam HE, Ahmed HB (2021) Antitumor/antiviral carbon quantum dots based on carrageenan
and pullulan. Int J Biol Macromol 170:688–700
46. Zhou Y, Liyanage PY, Devadoss D, Guevara LRR, Cheng L, Graham RM, Graham HS, Chand
HS, Al-Youbi AO, Bashammakh AS (2019) Nontoxic amphiphilic carbon dots as promising
drug nanocarriers across the blood–brain barrier and inhibitors of β-amyloid. Nanoscale
11(46):22387–22397
47. Cutrim ES, Vale AA, Manzani D, Barud HS, Rodriguez-Castellon E, Santos AP, Alcântara
AC (2021) Preparation, characterization and in vitro anticancer performance of nanoconjugate
based on carbon quantum dots and 5-Fluorouracil. Mater Sci Eng C 120:111781
48. Yuan Y, Guo B, Hao L, Liu N, Lin Y, Guo W, Li X, Gu B (2017) Doxorubicin-loaded
environmentally friendly carbon dots as a novel drug delivery system for nucleus targeted
cancer therapy. Colloids Surf B 159:349–359
49. Sharma N, Sharma I, Bera MK (2022) Microwave-Assistedgreen synthesis of carbon quantum
dots derived from Calotropis Gigantea as a fluorescent probe for bioimaging. J. Fluorescence
32(3):1039–1049
50. Ostovar S, Pourmadadi M, Shamsabadipour A, Mashayekh P (2023) Nanocomposite of
chitosan/gelatin/carbon quantum dots as a biocompatible and efficient nanocarrier for
improving the Curcumin delivery restrictions to treat brain cancer. Int J Biol Macromol
242:124986
51. Karami MH, Pourmadadi M, Abdouss M, Kalaee MR, Moradi O, Rahdar A, Díez-Pascual
AM (2023) Novel chitosan/γ-alumina/carbon quantum dot hydrogel nanocarrier for targeted
drug delivery. Int. J. Biol. Macromol. 126280
52. Rahmani E, Pourmadadi M, Ghorbanian SA, Yazdian F, Rashedi H, Navaee M (2022)
Preparation of a pH-responsive chitosan-montmorillonite-nitrogen-doped carbon quantum
dots nanocarrier for attenuating doxorubicin limitations in cancer therapy. Eng Life Sci
22(10):634–649

290 M. Pourmadadi et al.
53. Mathew SA, Praveena P, Dhanavel S, Manikandan R, Senthilkumar S, Stephen A (2020)
Luminescent chitosan/carbon dots as an effective nano-drug carrier for neurodegenerative
diseases. RSC Adv 10(41):24386–24396
54. Han C, Zhang X, Wang F, Yu Q, Chen F, Shen D, Yang Z, Wang T, Jiang M, Deng T,
Yu C (2021) Duplex metal co-doped carbon quantum dots-based drug delivery system with
intelligent adjustable size as adjuvant for synergistic cancer therapy. C. 183:789–808
55. Gogoi N, Chowdhury D (2014) Novel carbon dot coated alginate beads with superior stability,
swelling and pH responsive drug delivery. J Mater Chem B 2(26):4089
56. Su W,Guo R, Yuan F, Li Y,Li X, Zhang Y, Zhou S, Fan L (2020) Red-emissive carbon quantum
dots for nuclear drug delivery in cancer stem cells. J Phys Chem Lett 11(4):1357–1363
57. Ankireddy SR, Vo VG, An SSA, Kim J (2020) Solvent-free synthesis of fluorescent carbon
dots: an ecofriendly approach for the bioimaging and screening of anticancer activity via
caspase-induced apoptosis. ACS Appl Bio Mater 3(8):4873–4882
58. Ganguly S, Das P, Itzhaki E, Hadad E, Gedanken A, Margel S (2020) Microwavesynthesized polysaccharide-derived carbon dots as therapeutic cargoes and toughening agents
for elastomeric gels. ACS Appl Mater Interfaces 12(46):51940–51951
59. Sheng Y, Dai W, Gao J, Li H, Tan W, Wang J, Deng L, Kong Y (2020) PH-sensitive
drug delivery based on chitosan wrapped graphene quantum dots with enhanced fluorescent
stability. Mater Sci Eng C 112:110888
60. Zhang J, Liu X, Wang X, Mu L, Yuan M, Liu B, Shi H (2018) Carbon dots-decorated
Na2W4O13 composite with WO3 for highly efficient photocatalytic antibacterial activity.
J Hazard Mater 359:1–8
61. Lin L, Luo Y, Tsai P, WangJ, Chen X (2018) Metal ions doped carbon quantum dots: Synthesis,
physicochemical properties, and their applications. TrAC, Trends Anal. Chem. 103, 87–101
62. Zoghi M, Pourmadadi M, Yazdian F, Nigjeh MN, Rashedi H, Sahraeian R (2023) Synthesis
and characterization of chitosan/carbon quantum dots/Fe2O3 nanocomposite comprising
curcumin for targeted drug delivery in breast cancer therapy. Int J Biol Macromol 249:125788
63. Sharma A, Das J (2019) Small molecules derived carbon dots: synthesis and applications in
sensing, catalysis, imaging, and biomedicine. J Nanobiotechnol 17(1):1–24
64. Moradlou O, Rabiei Z, Delavari N (2019) Antibacterial effects of carbon quantum dots@
hematite nanostructures deposited on titanium against Gram-positive and Gram-negative
bacteria. J. Photochem Photobiol. A: Chemistry. 379:144–149
65. Wang H, Cao G, Gai Z, Hong K, Banerjee P, Zhou S (2015) Magnetic/NIR-responsive drug
carrier,multicolor cell imaging, and enhanced photothermal therapy of gold capped magnetitefluorescent carbon hybrid nanoparticles. Nanoscale 7(17):7885–7895
66. Wen Y, Xu M, Liu X, Jin X, Kang J, Xu D, Sang H, Gao P, Chen X, Zhao L (2019) Magnetofluorescent nanohybrid comprising polyglycerol grafted carbon dots and iron oxides: Colloidal
synthesis and applications in cellular imaging and magnetically enhanced drug delivery.
Colloid. Surf. B 173, 842–50
67. Wang H, Shen J, Li Y,WeiZ, Cao G, Gai Z, Hong K, Banerjee P, Zhou S (2014) Magnetic iron
oxide–fluorescent carbon dots integrated nanoparticles for dual-modal imaging, near-infrared
light-responsive drug carrier and photothermal therapy. Biomater Sci 2(6):915–923
68. Pandey S, Thakur M, Mewada A, Anjarlekar D, Mishra N, Sharon M (2013) Carbon dots
functionalized gold nanorod mediated delivery of doxorubicin: tri-functional nano-worms for
drug delivery, photothermal therapy and bioimaging. J Mater Chem B 1(38):4972–4982
69. Chung S, Zhang M (2021) Microwave-assisted synthesis of carbon dot–iron oxide nanoparticles for fluorescence imaging and therapy. Front. Bioeng. Biotechnol. 9:711534
70. Barhoum A, Meftahi A, Kashef Sabery MS, Momeni Heravi ME, Alem F (2023) A review
on carbon dots as innovative materials for advancing biomedical applications: synthesis,
opportunities, and challenges. J. Mater. Sci. 58(34):13531–79
71. Seven ES, Seven YB, Zhou Y, Poudel-Sharma S, Diaz-Rucco JJ, Cilingir EK, Mitchell GS,
Van Dyken JD, Leblanc RM (2021) Crossing the blood–brain barrier with carbon dots: uptake
mechanism and in vivo cargo delivery. Nanoscale Adv. 3(13):3942–3953

Carbon Quantum Dots Based Materials for Drug Delivery 291
72. Li LL, Ji J, Fei R, Wang CZ, Lu Q, Zhang JR, Jiang LP, Zhu JJ (2012) A facile microwave
avenue to electrochemiluminescent two-color graphene quantum dots. Adv Funct Mater
22(14):2971–2979
73. Saha B, Shaji S, Debnath A (2023) Fabrication of polyaniline based calcium ferrite nanocomposite and its application in sequestration of Victoria blue dye from wastewater. J Dispers Sci
Technol 1–15
74. Yao YY, Gedda G, Girma WM, Yen CL, Ling YC, Chang JY (2017) Magnetofluorescent
carbon dots derived from crab shell for targeted dual-modality bioimaging and drug delivery.
ACS Appl Mater Interfaces 9(16):13887
75. Kumar KM, Mukeshchand T, Rohit S (2017) Graphene Quantum Dots from Mangifera indica:
Application in Near-Infrared Bioimaging and Intracellular Nanothermometry. ACS Sustain.
Chem. Eng. 5(2):1382–1391
76. Pires NR, Santos CM, Sousa RR, Paula R, Cunha PL, Feitosa J (2015) Novel and fast
microwave-assisted synthesis of carbon quantum dots from raw cashew gum. J Braz Chem
Soc 26:1274–1282
77. Ren Q, Ga L, Ai J (2019) Rapid synthesis of highly fluorescent nitrogen-doped graphene
quantum dots for effective detection of ferric ions and as fluorescent ink. ACS Omega
4(14):15842–15848
78. Fattahi Nafchi R, Ahmadi R, Heydari M, Rahimipour MR, Molaei MJ, Unsworth L (2022) In
vitro study: synthesis and evaluation of Fe3O4/CQD magnetic/fluorescent nanocomposites for
targeted drug delivery, MRI, and cancer cell labeling applications. Langmuir 38(12), 3804–16
79. Pei M, Pai JY, Du P, Liu P (2018) Facile synthesis of fluorescent hyper-cross-linked β-
cyclodextrin-carbon quantum dot hybrid nanosponges for tumor theranostic application with
enhanced antitumor efficacy. Mol. Pharmaceutics 15(9):4084–4091
80. Li Y, Shi N, Zhang W, Zhang H, Song Y, Zhu W, Feng X (2020) Supramolecular hybrids of
carbon dots and dihydroartemisinin for enhanced anticancer activity and mechanism analysis.
J Mater Chem B 8(42):9777–9784
81. Sun X, Chen M, Zhang Y, Yin Y, Zhang L, Li H, Hao J (2018) Photoluminescent and
pH-responsive supramolecular structures from co-assembly of carbon quantum dots and
zwitterionic surfactant micelles. J Mater Chem B 6(43):7021–7032
82. Wang H, Sun Y, Yi J, Fu J, Di J, del Carmen Alonso A, Zhou S (2015) Fluorescent porous
carbon nanocapsules for two-photon imaging, NIR/pH dual-responsive drug carrier, and
photothermal therapy. Biomater 53:117–26
83. Alijani H, Noori A, Faridi N, Bathaie SZ, Mousavi MF (2020) Aptamer-functionalized
Fe3O4@ MOF nanocarrier for targeted drug delivery and fluorescence imaging of the
triple-negative MDA-MB-231 breast cancer cells. J Solid State Chem 292:121680
84. Chen Y, Cheng H, Wang W, Jin Z, Liu Q, Yang H, Cao Y, Li W, Fakhri A, Gupta VK
(2021) Preparation of carbon dots-hematite quantum dots-loaded hydroxypropyl cellulosechitosan nanocomposites for drug delivery, sunlight catalytic and antimicrobial application.
J Photochem Photobiol B 219:112201
85. Chowdhuri AR, Singh T, Ghosh SK, Sahu SK (2016) Carbon dots embedded magnetic
nanoparticles@ chitosan@ metal organic framework as a nanoprobe for pH sensitive targeted
anticancer drug delivery. ACS Appl Mater Interfaces 8(26):16573–16583
86. Lin C, Sun K, Zhang C, Tan T, Xu M, Liu Y, Xu C, Wang Y, Li L, Whittaker A (2020) Carbon
dots embedded metal organic framework@ chitosan core-shell nanoparticles for vitro dual
mode imaging and pH-responsive drug delivery. Microporous Mesoporous Mater 293:109775
87. Qin YT, Feng YS, Ma YJ, He XW, Li WY, Zhang YK (2020) Tumor-sensitive biodegradable nanoparticles of molecularly imprinted polymer-stabilized fluorescent zeolitic imidazolate framework-8 for targeted imaging and drug delivery. ACS Appl Mater Interfaces
12(22):24585–24598
88. Wang H, Wang K, Tian B, Revia R, Mu Q, Jeon M, Chang FC, Zhang M (2016) Preloading
of Hydrophobic Anticancer Drug into Multifunctional Nanocarrier for Multimodal Imaging,
NIR-Responsive Drug Release, and Synergistic Therapy. Small 12(46):6388–6397

292 M. Pourmadadi et al.
89. Hashemi F, Mohajeri N, Radnia F, Zarghami N (2022) Design of an efficient fluorescent
nanoplatform carrier for hydrophobic drugs along with green carbon dot: Possible application
in cancer image-guided drug therapy. Photodiagnosis Photodyn Ther 37:102738
90. Shamsipour M, Mansouri AM, Moradipour P (2019) Temozolomide conjugated carbon
quantum dots embedded in core/shell nanofibers prepared by coaxial electrospinning as an
implantable delivery system for cell imaging and sustained drug release. AAPS Pharm Sci
Tech 20:1–14
91. Duan Q, Ma L, Zhang B, Zhang Y, Li X, Wang T, Zhang W, Li Y, Sang S (2020) Construction and application of targeted drug delivery system based on hyaluronic acid and heparin
functionalised carbon dots. Colloids Surf B 188:110768
92. Hua XW, Bao YW, Wu FG (2018) Fluorescent carbon quantum dots with intrinsic nucleolustargeting capability for nucleolus imaging and enhanced cytosolic and nuclear drug delivery.
ACS Appl Mater Interfaces 10(13):10664–10677
93. Samimi S, Ardestani MS, Dorkoosh FA (2021) Preparation of carbon quantum dots-quinic acid
for drug delivery of gemcitabine to breast cancer cells. J Drug Deliv Sci Technol 61:102287
94. Zavareh HS, Pourmadadi M, Moradi A, Yazdian F, Omidi M (2020) Chitosan/carbon quantum
dot/aptamer complex as a potential anticancer drug delivery system towards the release of
5-fluorouracil. Int J Biol Macromol 165:1422–1430
95. Shao Y, Zhu C, Fu Z, Lin K, Wang Y, Chang Y, Han L, Yu H, Tian F (2020) Tian, Green
synthesis of multifunctional fluorescent carbon dots from mulberry leaves (Morus alba L.)
residues for simultaneous intracellular imaging and drug delivery. J Nanopart Res 22:1–11
96. Sarkar S, Das K, Das PK (2017) Estradiol hemisuccinate-modified surface-engineered carbon
dots: target-specific theranostic agent. ACS Sustain. Chem. Eng. 5(9):8356–8369
97. Ardekani SM, Dehghani A, Hassan M, Kianinia M, Aharonovich I, Gomes VG (2017)
Two-photon excitation triggers combined chemo-photothermal therapy via doped carbon
nanohybrid dots for effective breast cancer treatment. Chem Eng J 330:651–662
98. Khodadadei F, Safarian S, Ghanbari N (2017) Methotrexate-loaded nitrogen-doped graphene
quantum dots nanocarriers as an efficient anticancer drug delivery system. Mater Sci Eng C
79:280–285
. Liu X, Shou D, Chen C, Mao H, Kong Y, Tao Y (2017) Core-shell structured polypyr-
role/mesoporous SiO2 nanocomposite capped with graphene quantum dots as gatekeeper for
irradiation-controlled release of methotrexate. Mater Sci Eng C 81:206–212
100. Chowdhury AD, Ganganboina AB, Tsai YC, Chiu HC, Doong RA (2018) Multifunctional
GQDs-Concanavalin A@ Fe3O4 nanocomposites for cancer cells detection and targeted drug
delivery. Anal Chim Acta 1027:109–120
101. Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP (2021) Recent advances
in tumor targeting via EPR effect for cancer treatment. J. Pers. Med. 11(6):571
102. Zrazhevskiy P, Sena M, Gao X (2010) Designing multifunctional quantum dots for
bioimaging, detection, and drug delivery. Chem Soc Rev 39(11):4326–4354
103. Singh KR, Nayak V, Sabui P, Mallick S, Singh J, Singh RP (2022) Bioinspired quantum dots:
promising nanosystems for biomedical application. Nano-Struct Nano-Obj 32:100921
104. Pandey P, Dahiya M (2016) A brief review on inorganic nanoparticles. J Crit Rev 3(3):18–26
105. Wang Y, Chen L (2011) Quantum dots, lighting up the research and development of
nanomedicine. Nanomed Nanotechnol Biol Med 7(4):385–402
106. Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC (2012) Interactions of
nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug
Deliv Rev 64(13):1363–1384
107. Kevadiya BD, Ottemann BM, Thomas MB, Mukadam I, Nigam S, McMillan J, Gorantla S,
Bronich TK, Edagwa B, Gendelman HE (2019) Neurotheranostics as personalized medicines.
Adv Drug Deliv Rev 148:252–289

Carbon-based Nanocarriers for Sustained Drug Release in Dentistry
Abhisikta Biswal
Abstract Nanotechnology and nanoscience have dominated the scientific world by
providing highly functional and efficient materials to be used in every facet of dayto-day life. Such a class of functional nanomaterials is the Carbon-based nanomaterials (CBNs), which envelops the nano-dimensional materials comprised of carbon
atoms possessing miraculous properties. The CBNs offer higher levelperformance in
various biomedical applications including drug delivery, tissue engineering, wound
healing, biosensing and bioimaging fields. The present chapter covers the potent
application of CBNs for controlled local release of therapeutics along with its superiority over conventional drug delivery modes used for dental diseases. Various types
of CBNs used for dental drug delivery are summarized and discussed in details to
bring forward the vast efficacy of CBNs in dentistry, which still remains a grey area
in nanoscience. The chapter includes five illustrative figures to offer better relevance
with the text, for the convenience of the readers.
Keywords Dentistry
nanomaterials
· Oral mucosa · Odontogenic infections · Carbon
·
Drug delivery
1 Introduction
Oral cavity is a composite biological environment due to its specific microbial flora
and ability to endure physical, chemical and pathological changes while maintaining
a homeostatic balance to carry out physiological functions. Oral diseases have been
generally treated by administering drugs systemically. There are a variety of routes
of drug administration i.e., oral, parenteral, submucosal, intra muscular and others.
These systemic routes of drug administration have certain drawbacks of reduced
bio-availability, drug resistance and undesirable effects on non-target tissues. Due to
these issues with traditional routes of drug delivery, the search for an effectivemethod
A. Biswal (B)
Department of Periodontics and Oral Implantology, Kalinga Institute of Dental Sciences, KIIT
Road, Patia, Bhubaneswar, Odisha, India
e-mail: biswalabhisikta@gmail.com
293

294 A. Biswal
of drug delivery was promoted. With developing research localized sustained drug
delivery systems in oral cavity came into effect [1]. Local drug delivery using drug
carriers have much improved characteristics including improved pharmacokinetics
and effectiveness,better power over drug release to desired targeted site which results
in higher bioavailability [1–3]. In sustained drug delivery system introduction of use
of drug carriers has improved the drug interaction with body tissue and reduces cross
reaction with other drug molecules rendering higher safety levels [1]. Drug carriers
have a wide range of use in dental practice such as: liquid dosage forms (solutions,
suspensions), semi-solid dosage forms (gels, creams, pastes), medicated chewing
gums, patches, films, strips. These are some of the conventional forms, to name a
few. The most common amongst these conventional forms of local drug delivery
system in a tissue are the semi solid and liquid forms. But their therapeutic effect
is lowered due to poor retention in oral cavity even though these traditional systems
have better patient acceptability and ease of administration [4–9]. To bridge over the
disadvantages of lower therapeutic effect, some improvements in terms of matrix
which are polymer based have been made for previously used forms of local drug
delivery system like PerioChip® (chlorhexidine in a matrix of hydrolysed gelatine) Actisite® (tetracycline in a polymer-based fibre), Atridox® (doxycycline in
an injectable form), Arestin® (minocycline microspheres made with poly lactic-coglycolic acid) [5, 10]. These developments have covered some of the disadvantages
of traditional drug delivery systems but the search for a newer developed version
of drug delivery is still continuing. Presently in the scenario of research there is an
increasing utilisation of nanomaterials in dentistry in the field of drug delivery [11,
12]. A wide variety of nanoparticles are being used in dentistry to incorporate the
benefits of nanotechnology in drug delivery so that it has efficient clinical use. As an
emerging inorganic nanomaterial under research, Carbon-based nanomaterials have
been categorised as superior when compared to others because it is structurally mesoporous and higher surface area, for which they are excellent drug deliveryagents [13]
(Fig. 10.1).
Nanoscale materials are available in a wide variety of forms like nanoparticles,
nano capsules, nanotubes, nanogels and dendrimers which are utilised for drug
delivery [14]. These drug delivery systems are accompanied by primary issues
of low efficacy and therapeutic profile [15]. Other problems encountered are sub
optimal bioavailability, ineffective targeting and potential cytotoxicity [14]. Hence
for biomedical utilisation, synthesis should be carefully conducted under specific
physical and chemical properties so as to have the desired solubility, immunocompatibility and cellular uptake. Nanotechnology has improved the characteristics of nanobiomedicine and treatment of the disease [16]. Drug delivery agents with enhanced
nanomaterials and better properties have improved uptake of drugs with poor solubility by the cells [17, 18] and bioavailability is increased significantly when lowered
doses of drug are administered. This has majorly been achieved due to physical characteristics of nano particles namely size and geometry, thus playing an important role
in biomedical drug delivery systems [19, 20]. Studies have shown that on changing
the geometry of nanoparticles there is a remarkable alteration in its transport to
the cellular target as well as in the rate at which drug is loaded on to the delivery
Соседние файлы в папке Библиотека им академика М.И. Перельмана
